JP2006525367A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006525367A5 JP2006525367A5 JP2006514246A JP2006514246A JP2006525367A5 JP 2006525367 A5 JP2006525367 A5 JP 2006525367A5 JP 2006514246 A JP2006514246 A JP 2006514246A JP 2006514246 A JP2006514246 A JP 2006514246A JP 2006525367 A5 JP2006525367 A5 JP 2006525367A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- dihydroxy
- compound
- vitamin
- cholecalciferol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CC(C)(CCC[C@@](CC[C@](C(C)(C)O)O)[C@@](CC1)[C@@](C)(CCC2)[*@@]1C2=CC=C(C[C@](C[C@@]1O)O)C1=C)O Chemical compound CC(C)(CCC[C@@](CC[C@](C(C)(C)O)O)[C@@](CC1)[C@@](C)(CCC2)[*@@]1C2=CC=C(C[C@](C[C@@]1O)O)C1=C)O 0.000 description 3
- OMCJRXSHPQKCJN-JDEGUXPNSA-N CC(C)(CCC[C@@H](CCC(C(C)(C)O)=O)[C@@H](CC1)[C@@](C)(CCC2)[C@@H]1/C2=C/C=C(C[C@H](C1)O)C[C@H]1O)O Chemical compound CC(C)(CCC[C@@H](CCC(C(C)(C)O)=O)[C@@H](CC1)[C@@](C)(CCC2)[C@@H]1/C2=C/C=C(C[C@H](C1)O)C[C@H]1O)O OMCJRXSHPQKCJN-JDEGUXPNSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46663803P | 2003-04-30 | 2003-04-30 | |
| PCT/US2004/013703 WO2004098522A2 (en) | 2003-04-30 | 2004-04-30 | Gemini vitamin d3 compounds and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006525367A JP2006525367A (ja) | 2006-11-09 |
| JP2006525367A5 true JP2006525367A5 (enExample) | 2007-07-05 |
Family
ID=33434966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006514246A Pending JP2006525367A (ja) | 2003-04-30 | 2004-04-30 | ジェミニビタミンｄ３化合物及びその使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1622455A4 (enExample) |
| JP (1) | JP2006525367A (enExample) |
| AU (1) | AU2004235775A1 (enExample) |
| CA (1) | CA2524026A1 (enExample) |
| WO (1) | WO2004098522A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050192255A1 (en) * | 2003-07-30 | 2005-09-01 | Jin Tian | Use of Vitamin Ds or Vitamin D analogs to treat cardiovascular disease |
| US20070054887A1 (en) * | 2003-09-24 | 2007-03-08 | Bioxell S.P.A | Methods for treating bladder dysfunction |
| US20070134286A1 (en) * | 2004-12-02 | 2007-06-14 | Wu-Wong Jinshyun R | Methods for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals |
| JP2008538114A (ja) * | 2005-03-23 | 2008-10-09 | ビオクセル エッセ ピ ア | ２０−アルキル、ジェミニビタミンｄ３化合物及びその使用方法 |
| US20090298799A1 (en) * | 2005-03-23 | 2009-12-03 | Bioxell S.P.A. | Methods of Treating Osteoporosis and Secondary Hyperparathyroidism Using 20-Methyl, Gemini Vitamin D3 Compounds |
| US7286295B1 (en) | 2005-11-30 | 2007-10-23 | Sandia Corporation | Microoptical compound lens |
| CA2664049A1 (en) * | 2006-09-22 | 2008-03-27 | Bioxell Spa | Novel method |
| ES3047207T3 (en) * | 2007-04-25 | 2025-12-03 | Opko Renal Llc | Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease |
| AU2009337184A1 (en) * | 2009-01-16 | 2011-07-28 | Anzamed International Limited | Medicament for the treatment of pain and inflammation |
| CN104758300A (zh) * | 2014-01-02 | 2015-07-08 | 上海泽生科技开发有限公司 | 维生素d及其组合物的抗菌用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6030962A (en) * | 1997-04-28 | 2000-02-29 | Synttex (U.S.A.) Inc. | Vitamin D3 analogs with bis C-20 side chains |
| KR100351490B1 (ko) * | 1997-04-28 | 2002-09-05 | 에프. 호프만-라 로슈 아게 | 비스 씨-20 측쇄를 갖는 비타민 디3 유사체 |
| US6008209A (en) * | 1997-04-28 | 1999-12-28 | Hoffmann-La Roche Inc. | Method of using vitamin D3 analogs with bis C-20 side chains |
| US6017908A (en) * | 1997-05-16 | 2000-01-25 | Women And Infants Hospital | 3-EPI vitamin D2 compounds and uses thereof |
| US6331642B1 (en) * | 1999-07-12 | 2001-12-18 | Hoffmann-La Roche Inc. | Vitamin D3 analogs |
| US20030095937A1 (en) * | 2001-10-02 | 2003-05-22 | Koeffler H. Philip | Method for stimulating hair growth by administering vitamin D analogs |
-
2004
- 2004-04-30 EP EP04751195A patent/EP1622455A4/en not_active Withdrawn
- 2004-04-30 AU AU2004235775A patent/AU2004235775A1/en not_active Abandoned
- 2004-04-30 JP JP2006514246A patent/JP2006525367A/ja active Pending
- 2004-04-30 CA CA002524026A patent/CA2524026A1/en not_active Abandoned
- 2004-04-30 WO PCT/US2004/013703 patent/WO2004098522A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007506765A5 (enExample) | ||
| US10266496B2 (en) | Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof | |
| JP2020512315A5 (enExample) | ||
| JP2007525494A5 (enExample) | ||
| JP2009525981A5 (enExample) | ||
| CA2648036A1 (en) | Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor | |
| JP2016505019A5 (enExample) | ||
| JP2008514621A5 (enExample) | ||
| US20220267295A1 (en) | Crystalline forms of somatostatin modulators | |
| JP2017508733A5 (enExample) | ||
| CN1246119A (zh) | 吡咯并[3,4－d]－嘧啶酮衍生物及其作为药物的用途 | |
| JP2007504128A5 (enExample) | ||
| KR20220127900A (ko) | Jak 키나아제 관련 질병의 치료를 위한 약물의 제조에 있어서 jak 억제제의 용도 | |
| JP2008538114A5 (enExample) | ||
| RU2564414C2 (ru) | Новый агонист ер4 | |
| JP2013525490A5 (enExample) | ||
| JP5744003B2 (ja) | 抗ウイルス化合物を調製する方法 | |
| CA2598518C (en) | 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases | |
| SA518392275B1 (ar) | -2h-مشتق 5- ميثيل -6- فينيل -4، 5- داي هيدرو بيريدازين -3- أون | |
| JP2008520709A5 (enExample) | ||
| WO2006129688A1 (ja) | ２－アミノブタノール化合物及びその医薬用途 | |
| US8895769B2 (en) | Silicon-containing carboxylic acid derivative | |
| JPS6158449B2 (enExample) | ||
| JP2009143931A (ja) | テトラゾリルベンゾピランの製法 | |
| CA2448518A1 (en) | New compounds useful in reflux disease |